Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.68729 | 29 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.85901 | 38 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.67816 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.62801 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.61464 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.70181 | 28 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.67306 | 28 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.64589 | 29 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.64439 | 29 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.66141 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.66013 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.63301 | 29 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.64796 | 28 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.66596 | 30 |